"Rift Valley fever virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A mosquito-borne species of the PHLEBOVIRUS genus found in eastern, central, and southern Africa, producing massive hepatitis, abortion, and death in sheep, goats, cattle, and other animals. It also has caused disease in humans.
| Descriptor ID |
D012296
|
| MeSH Number(s) |
B04.820.087.710.700
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Rift Valley fever virus".
Below are MeSH descriptors whose meaning is more specific than "Rift Valley fever virus".
This graph shows the total number of publications written about "Rift Valley fever virus" by people in this website by year, and whether "Rift Valley fever virus" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Rift Valley fever virus" by people in Profiles.
-
Potent neutralizing human monoclonal antibodies protect from Rift Valley fever encephalitis. JCI Insight. 2024 Aug 01; 9(18).
-
Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses. Nat Commun. 2023 09 13; 14(1):5650.
-
A highly potent human neutralizing antibody prevents vertical transmission of Rift Valley fever virus in a rat model. Nat Commun. 2023 07 26; 14(1):4507.
-
Estimation of the Minimal Rift Valley Fever Virus Protective Neutralizing Antibody Titer in Human Volunteers Immunized with MP-12 Vaccine Based on Protection in a Mouse Model of Disease. Am J Trop Med Hyg. 2022 11 14; 107(5):1091-1098.
-
Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proc Natl Acad Sci U S A. 2021 04 06; 118(14).